2019
DOI: 10.32718/nvlvet9418
|View full text |Cite
|
Sign up to set email alerts
|

Acute and subacute toxicity of the drug based on tylosin tartrate

Abstract: The article presents the results of a study of the acute and subacute toxicity of the drug TILOTAR (a water-soluble powder for oral administration) made on the basis of tylosin tartrate. As a result of the research it was found that the drug "TILOTAR" refers to the 4th class of toxicity, that is, to low-toxic substances. After intragastric administration of the drug to white mice and rats at doses of 2500, 5000, 7500 mg/kg, all animals remained alive. Short-term inhibition was recorded in laboratory animals, w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
1
0
1

Year Published

2019
2019
2020
2020

Publication Types

Select...
2

Relationship

2
0

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 2 publications
0
1
0
1
Order By: Relevance
“…One of the key and mandatory prerequisites for the creation and testing of new veterinary products, feed additives, both in the context of compliance with national legislation and the requirements of the international community for their registration, is conducting of preclinical and clinical trials in compliance with Good Clinical Practice (GCP) requirements. Criteria for evaluating the efficiency and safety of the test products should not be limited only to safety and productivity but should also include characteristics of the morphofunctional state of the target animal species based on laboratory diagnosis (Anadon et al, 2006;Kocjumbas, & Lemishevskij, 2013;Zhуla, 2017;Todoriuk et al, 2018;Gutyj et al, 2018;Zhyla et al, 2019;Patereha et al, 2019).…”
Section: Introductionmentioning
confidence: 99%
“…One of the key and mandatory prerequisites for the creation and testing of new veterinary products, feed additives, both in the context of compliance with national legislation and the requirements of the international community for their registration, is conducting of preclinical and clinical trials in compliance with Good Clinical Practice (GCP) requirements. Criteria for evaluating the efficiency and safety of the test products should not be limited only to safety and productivity but should also include characteristics of the morphofunctional state of the target animal species based on laboratory diagnosis (Anadon et al, 2006;Kocjumbas, & Lemishevskij, 2013;Zhуla, 2017;Todoriuk et al, 2018;Gutyj et al, 2018;Zhyla et al, 2019;Patereha et al, 2019).…”
Section: Introductionmentioning
confidence: 99%
“…За допомогою гематологічних, біохімічних, патоморфологічних, імунологічних та інших методів проводиться вивчен-ня біологічної реакції організму тварин на дію ветеринарних лікарських засобів, що дозволяє скласти точне уявлення про характер і важкість перебігу патологічного процесу за дії досліджуваних речовин. Патоморфологічні методи дослідження істотно доповнюють картину загальної інтоксикації, характер і ступінь вираженості порушень у різних органах, тканинах та є обов'язковими в гострому і хронічному токсикологічному експерименті (Kosenko et al, 1997;Litvinova et al, 2001;Kotsiumbas et al, 2006;Gutyj et al, 2018;Todoriuk et al, 2018;Patereha et al, 2019).…”
Section: Introductionunclassified